Risperidone (LYN-005, long-acting formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Risperidone (LYN-005, long-acting formulation), covering 2025-04-08 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder [Phase 3]